MVA Vectored Vaccines Encoding Rift Valley Fever Virus Glycoproteins Protect Mice against Lethal Challenge in the Absence of Neutralizing Antibody Responses

In vitro neutralizing antibodies have been often correlated with protection against Rift Valley fever virus (RVFV) infection. We have reported previously that a single inoculation of sucrose-purified modified vaccinia Ankara (MVA) encoding RVFV glycoproteins (rMVAGnGc) was sufficient to induce a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gil, Elena, Moreno, Sandra, Ortego, Javier, Borrego, Belén, Lorenzo, Gema, Brun, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157666/
https://www.ncbi.nlm.nih.gov/pubmed/32059491
http://dx.doi.org/10.3390/vaccines8010082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157666/
https://www.ncbi.nlm.nih.gov/pubmed/32059491
http://dx.doi.org/10.3390/vaccines8010082

Ejemplares similares